Levosimendan versus dobutamine in septic cardiomyopathy: a randomized clinical trial on cardiac function and safety
Authors
- Leqing Lin (ORCID: https://orcid.org/0009-0006-5941-8585)
- Zhuxian Zhang (ORCID: https://orcid.org/0000-0002-7504-0758)
- Feng Zhao (ORCID: https://orcid.org/0000-0002-4441-9992)
- Hui Wang (ORCID: https://orcid.org/0000-0002-8549-3398)
- Liang Guo (ORCID: https://orcid.org/0009-0003-1968-0018)
- Hongxia Wei (ORCID: https://orcid.org/0009-0008-2153-9132)
Institutions
- Tongde Hospital of Zhejiang Province (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-09-19
- DOI
- https://doi.org/10.3389/fcvm.2025.1641604
- Citations
- 2
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.78